Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jan 3, 2020
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Iradimed Corp
| 293 |
$23.38 | -$2,221.10 | +0.55% | 53.47K |
Dec 31
| |||||||
Iradimed Corp
| 321 |
$25.67 | -$2,669.68 | +0.61% | 53.18K |
Dec 14
| |||||||
Iradimed Corp
| 297 |
$22.88 | -$2,196.48 | +0.57% | 52.86K |
Dec 7
| |||||||
Iradimed Corp
| 558 |
$22.28 | -$4,010.40 | +1.07% | 52.56K |
Dec 4
| |||||||
Iradimed Corp
| 293 |
$24.46 | -$2,323.70 | +0.57% | 52.01K |
Dec 31
| |||||||
Iradimed Corp
| 321 |
$27.02 | -$2,810.08 | +0.62% | 51.71K |
Dec 14
| |||||||
Iradimed Corp
|
0
|
—
|
—
|
—
|
0
|
Dec 7
| |||||||
Iradimed Corp
| 560 |
$26.78 | -$4,766.84 | +1.10% | 51.39K |
Dec 4
| |||||||
Iradimed Corp
| -55.00K |
$29.30 | -$1,611,403.55 | -51.97% | 50.83K |
Sep 13 - Sep 14
| |||||||
Iradimed Corp
| -35.00K |
$18.50 | -$647,524.50 | -24.85% | 105.83K |
Jun 13
| |||||||
Iradimed Corp
| 285 |
$15.15 | -$1,560.45 | +0.20% | 140.83K |
Dec 31
| |||||||
Iradimed Corp
| 286 |
$13.10 | -$1,820.90 | +0.20% | 140.55K |
Dec 14
| |||||||
Iradimed Corp
|
0
|
—
|
—
|
—
|
0
|
Dec 4
| |||||||
Iradimed Corp
| 260 |
$12.30 | -$1,562.10 | +0.19% | 140.26K |
Jan 4
| |||||||
Iradimed Corp
|
0
|
—
|
—
|
—
|
0
|
Dec 14
| |||||||
Iradimed Corp
|
0
|
—
|
—
|
—
|
0
|
Jan 4
| |||||||
Iradimed Corp
|
0
|
—
|
—
|
—
|
0
|
Dec 15
| |||||||
Iradimed Corp
| 140K |
—
|
—
|
∞
| 140K |
Jul 21
| |||||||
Iradimed Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |